Cardiovascular Effects of CAR T Cell Therapy
Background: Anti-CD19 chimeric antigen receptor (CAR) T cell therapy holds great promise in the treatment of patients with hematologic malignancies. A high occurrence of cardiac dysfunction has been noted in children treated with CAR T cell therapy. Objectives: The aim of this study was to define th...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | JACC. CardioOncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666087320300831 |